15 unchanged sentences
Purchases of Equity Securities by the Issuer
−Removed: The following table reflects share repurchases of our common stock for the three months ended December 31, 2023:
−Removed: Total Number of Shares Purchases
−Removed: Average Price Paid per Share
−Removed: Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)
−Removed: Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (1)
−Removed: October 1, 2023 to October 31, 2023
−Removed: November 1, 2023 to November 30, 2023
−Removed: December 1, 2023 to December 31, 2023
−Removed: (1) On October 31, 2022, the Board of Directors of Innoviva authorized and approved a stock repurchase program pursuant to which we may purchase up to $100.0 million of our outstanding common stock.
−Removed: The timing and amount of any share repurchases under the share repurchase program will be determined by Innoviva’s management in its discretion based on ongoing assessments of the capital needs of the business, the market price of Innoviva’s common stock, prevailing stock prices, general market conditions and other considerations.
−Removed: Share repurchases under the program may be made through a variety of methods, which may include open market purchases, privately negotiated transactions, in block trades, accelerated share repurchase transactions, exchange transactions, or any combination thereof or by other means in accordance with federal securities laws.
−Removed: This program has no termination date, may be suspended or discontinued at any time at the Company’s discretion and does not obligate the Company to acquire any amount of common stock.
+Added: During the year ended December 31, 2024, we did not repurchase shares of our common stock other than as disclosed in our Quarterly Report on Form 10-Q for the quarters ended March 31 and June 30, 2024.
Stock Performance Graph
7 unchanged sentences
Among Innoviva, Inc., the Nasdaq Composite Index, Nasdaq Biotechnology Index, and Nasdaq S&P Small Cap 600 Pharma Index.
+Added: _________________________________________________________
* $100 invested on December 31, 2019 in stock or index, including reinvestment of dividends.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.